BI Asset Management Fondsmaeglerselskab A S reduced its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 60.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,458 shares of the real estate investment trust's stock after selling 131,044 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Healthpeak Properties were worth $1,753,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. grew its position in shares of Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Norges Bank purchased a new stake in shares of Healthpeak Properties in the 4th quarter valued at approximately $166,804,000. Long Pond Capital LP acquired a new position in Healthpeak Properties during the fourth quarter worth $86,885,000. JPMorgan Chase & Co. boosted its holdings in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Finally, National Bank of Canada FI grew its holdings in shares of Healthpeak Properties by 56,120.9% in the fourth quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock valued at $34,181,000 after purchasing an additional 1,683,066 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Price Performance
Shares of DOC stock traded down $0.97 during mid-day trading on Friday, reaching $17.84. The stock had a trading volume of 11,084,354 shares, compared to its average volume of 4,913,024. The company has a market cap of $12.48 billion, a P/E ratio of 50.97, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. Healthpeak Properties, Inc. has a 12-month low of $17.33 and a 12-month high of $23.26. The business has a 50-day simple moving average of $19.57 and a 200 day simple moving average of $20.57. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The business also recently declared a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be given a dividend of $0.1017 per share. This represents a yield of 6.5%. The ex-dividend date of this dividend is Thursday, April 17th. Healthpeak Properties's payout ratio is 348.57%.
Analysts Set New Price Targets
Several brokerages recently weighed in on DOC. Scotiabank reduced their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. Wedbush restated an "outperform" rating and issued a $24.00 target price on shares of Healthpeak Properties in a research note on Friday, April 11th. Robert W. Baird lowered their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Tuesday, February 11th. StockNews.com downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday. Finally, Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $23.83.
Get Our Latest Stock Analysis on DOC
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.